Dr
Dr Mark Harries
Oncology
About
Dr Harries graduated from Cambridge University and underwent clinical training at the Royal London Hospital. He then trained in medical oncology at the Royal Marsden Hospital and completed a PhD and post-doctoral work in the Department of Immunology at University College, London. His research interests include immunotherapy for melanoma and breast cancer as well as clinical trials of new biological agents for these diseases.
He has published many papers and presents on a regular basis at national and international conferences. He is the Oncology Editor for the International Journal of Clinical Practice. Dr Harries is also an honorary senior lecturer at King's College London School of Medicine.
Diseases, Medical Tests and Treatments
• Chemotherapy
• Immunotherapy
• Biological therapy
• Hormonal therapy
• Breast Cancer
• Melanoma
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Mark Harries
Education & training
-
2014–2020 MD · Medicine and Surgery
-
2020–2024 Residency · Oncology
-
2024–2025 Fellowship · Subspecialty training
Career & appointments
-
2024-09–2025-08 Junior consultant
Licenses & insurance
Medical licenses
Board certifications
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 998 |
| Annual physical exam | 99395 | 760 |
| Vaccination administration | 90471 | 2,120 |
| Minor procedure (skin) | 17110 | 2,319 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 60 min | in_clinic | 450.00 EUR |
| Minor procedure (skin) | 90 min | in_clinic | 180.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 3 · i10: 4
-
European registry analysis of Oncology outcomes
DOI: 10.8603/euroclin.2025.0 · PMID: 33313569 · cited by 78
-
Outcomes of Oncology in adults — a multi-centre cohort
DOI: 10.9378/euroclin.2024.1 · PMID: 36587863 · cited by 116
-
European registry analysis of Oncology outcomes
DOI: 10.7992/euroclin.2023.2 · PMID: 32748612 · cited by 42
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional
Society memberships
- WONCA Europe — Family Doctors — Member · since 2025
- national college of family doctors — Member · since 2025
- European Union of Medical Specialists (UEMS) — Member · since 2025
Patient reviews
- Bedside Manner
- 0.05
- Knowledge
- 0.08
- Wait Time
- 3.80
- Staff Friendliness
- 0.02
- Ease Of Appointment
- 4.00
- Value For Money
- 4.10
- Would Recommend Pct
- 4
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · dr.mark.harries@euroclinics.example